Orphazyme makes changes to board of directors
Andrew Mercieca will be proposed as member of the Board of Directors at Orphazyme in April following Thursday's announcement that Catherine Moukheibir will step down from her position.
by marketwire, translated by daniel pedersen
Orphazyme has appointed Andrew Mercieca as observer and consultant to the board, intending to formally appoint him member at the company's annual general meeting in April, it reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme no longer expects EMA decision this year
For subscribers
.jpg&w=384&q=75)
